Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126487362 | 12648736 | 2 | F | 20160812 | 20160812 | 20160816 | EXP | GB-JNJFOC-20160808096 | JANSSEN | 0.00 | F | Y | 0.00000 | 20160816 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126487362 | 12648736 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | U | 50718 | LIPOSOME INJECTION | ||||||||
| 126487362 | 12648736 | 2 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126487362 | 12648736 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126487362 | 12648736 | 4 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126487362 | 12648736 | 5 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126487362 | 12648736 | 1 | Diffuse large B-cell lymphoma |
| 126487362 | 12648736 | 2 | Diffuse large B-cell lymphoma |
| 126487362 | 12648736 | 3 | Diffuse large B-cell lymphoma |
| 126487362 | 12648736 | 4 | Diffuse large B-cell lymphoma |
| 126487362 | 12648736 | 5 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126487362 | 12648736 | OT |
| 126487362 | 12648736 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126487362 | 12648736 | Body temperature increased | |
| 126487362 | 12648736 | Disease progression | |
| 126487362 | 12648736 | Infection | |
| 126487362 | 12648736 | Neoplasm progression | |
| 126487362 | 12648736 | Off label use | |
| 126487362 | 12648736 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |